Hudson Bay Capital Management’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Other funds holding APYX
RA
NCM
ACM
EIM
ACM
SBCM
HKAM
Hudson Bay Capital Management's APYX Position: Q2 2026 in Review
Hudson Bay Capital Management sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 54,001 shares — an estimated $199K sold.
Hudson Bay Capital Management first reported a position in APYX in Q4 2025 and held it in 2 quarters. The position peaked at $199K in Q1 2026. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.
- Hudson Bay Capital Management reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
- Hudson Bay Capital Management sold 54,001 Apyx Medical shares in Q2 2026, an estimated $199K.
- Hudson Bay Capital Management first reported a position in Apyx Medical in Q4 2025 and held it in 2 quarters.
- Hudson Bay Capital Management's Apyx Medical position peaked at $199K in Q1 2026.
- 67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.
Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.